TBS6b 是一种具有三甲氧基苯基和苯并咪唑修饰的黄酮类衍生物,作为高效且选择性的 ACKR3 分子胶 (molecular glue) 降解剂,它通过泛素-蛋白酶体途径降解 ACKR3,抑制肝细胞癌细胞的增殖、迁移和侵袭,因而与肝细胞癌研究相关。
TBS6b
产品编号: MS-G83958 分子式: C29H28N2O6 分子量: 500.54
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

TBS6b 是一种具有三甲氧基苯基和苯并咪唑修饰的黄酮类衍生物,作为高效且选择性的 ACKR3 分子胶 (molecular glue) 降解剂,它通过泛素-蛋白酶体途径降解 ACKR3,抑制肝细胞癌细胞的增殖、迁移和侵袭,因而与肝细胞癌研究相关。

生物实验数据

生物活性 TBS6b is a flavonoid derivative modified with trimethoxyphenyl and benzimidazole moieties that acts as a highly efficient and selective ACKR3 molecular glue degrader, degrading ACKR3 via the ubiquitin-proteasome pathway, inhibiting the proliferation, migration, and invasion of hepatocellular carcinoma cells, and is therefore relevant to hepatocellular carcinoma research.
IC50 & Target

ACKR3

 

体外研究
(In Vitro)

TBS6b (0-4 μM; 48 h; HCCLM3 and HepG2 cells) 减少细胞增殖、迁移和侵袭。
TBS6b (0-4 μM; 48 h; HCCLM3 and HepG2 cells) 以剂量依赖的方式下调增殖和间质标志物 (PCNA、N-钙黏蛋白和波形蛋白) 的表达,同时上调上皮标志物 E-钙黏蛋白的表达。TBS6b 选择性抑制 ACKR3 蛋白的表达,而不改变其 mRNA 水平。

Cell Proliferation Assay

Cell Line: HCCLM3 and HepG2 cells
Concentration: 0 μM, 1 μM, 2 μM, 4 μM
Incubation Time: 48 h
Result: Significantly reduced cell proliferation in a dose-dependent manner.

Cell Migration Assay

Cell Line: HCCLM3 and HepG2 cells
Concentration: 0 μM, 1 μM, 2 μM, 4 μM
Incubation Time: 48 h
Result: Significantly reduced cell migration in a dose-dependent manner.

Cell Invasion Assay

Cell Line: HCCLM3 and HepG2 cells
Concentration: 0 μM, 1 μM, 2 μM, 4 μM
Incubation Time: 48 h
Result: Significantly reduced cell invasion in a dose-dependent manner.

Western Blot Analysis

Cell Line: HCCLM3 and HepG2 cells
Concentration: 0 μM, 1 μM, 2 μM, 4 μM
Incubation Time: 48 h
Result: Selectively inhibits ACKR3 protein expression without altering its mRNA levels.
体内研究
(In Vivo)

TBS6b (5 mg/kg;IP;每隔一天;14 天) 抑制小鼠肝细胞癌肿瘤生长和转移,且没有显著毒性。
TBS6b (5 mg/kg;腹腔注射;隔日一次;持续 4 周) 可减少小鼠肺转移模型中的转移,且对肝脏或肾脏组织无显著影响。

Animal Model: Male Balb/c-Foxn1nu mice (4-5 weeks) were subcutaneously injected with 1 × 107 cells/mL sh-NC and sh-ACKR3 (derived from HCCLM3) and NC and ACKR3 (derived from HepG2) cells.
Dosage: 5 mg/kg
Administration: IP; every other day; 14 days
Result: Suppressed tumor growth and metastasis without inducing significant toxicity, as evidenced by stable body weight, normal organ histology, and unchanged serum levels of ALT, AST, BUN, and CRE.
Animal Model: Male Balb/c-Foxn1nu mice (4-5 weeks) were intravenously injected with 1 × 107 cells/mL sh-NC and sh-ACKR3 (derived from HCCLM3) and NC and ACKR3 (derived from HepG2) cells.
Dosage: 5 mg/kg
Administration: IP; every other day; 4 weeks
Result: Reduced metastasis. Decreased levels of Ki67, N-cadherin, and Vimentin, and increased E-cadherin in HCCLM3 cells, with no marked difference between combined and single-agent treatments.

化学信息

分子量 500.54
分子式 C29H28N2O6

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础